These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 23001252)

  • 1. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.
    Savarino E; Zentilin P; Mastracci L; Dulbecco P; Marabotto E; Gemignani L; Bruzzone L; de Bortoli N; Frigo AC; Fiocca R; Savarino V
    J Gastroenterol; 2013 Apr; 48(4):473-82. PubMed ID: 23001252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
    Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
    World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry].
    Maev IV; Yurenev GL; Barkalova EV; Ovsepian MA; Andreev DN; Shaburov RI
    Ter Arkh; 2024 Sep; 96(8):757-763. PubMed ID: 39404720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn.
    Chu C; Du Q; Li C; Zhang L; Zhou X; Zuo F; Zhang Y; Li F; Xie G; Li Y
    PLoS One; 2017; 12(4):e0175263. PubMed ID: 28384225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G; Kamal A; Clarke JO
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Gemignani L; Malesci A; Savarino V
    J Gastroenterol; 2012 Feb; 47(2):159-68. PubMed ID: 22038553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of dilated intercellular space and histopathologic scores in gastroesophageal reflux disease.
    Cui R; Zhang H; Zhou L; Lu J; Xue Y; Wang Y; Yan X; Lin L; Lin S
    Dis Esophagus; 2015; 28(6):530-7. PubMed ID: 25130660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease.
    Savarino E; Pohl D; Zentilin P; Dulbecco P; Sammito G; Sconfienza L; Vigneri S; Camerini G; Tutuian R; Savarino V
    Gut; 2009 Sep; 58(9):1185-91. PubMed ID: 19460766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease.
    Rengarajan A; Pomarat M; Zerbib F; Gyawali CP
    Neurogastroenterol Motil; 2021 Jun; 33(6):e14056. PubMed ID: 33300667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
    Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
    Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
    Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
    J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non-erosive reflux disease patients.
    Nikaki K; Woodland P; Lee C; Ghisa M; Marinelli C; Savarino E; Sifrim D
    Neurogastroenterol Motil; 2019 Sep; 31(9):e13667. PubMed ID: 31225933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.
    Yoshimine T; Funaki Y; Kawamura Y; Tamura Y; Izawa S; Ebi M; Ogasawara N; Murotani K; Sasaki M; Kasugai K
    Digestion; 2019; 99(2):157-165. PubMed ID: 30179879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.